切换至 "中华医学电子期刊资源库"

中华针灸电子杂志 ›› 2015, Vol. 04 ›› Issue (06) : 255 -258. doi: 10.3877/cma.j.issn.2095-3240.2015.06.002

论著

清肾排毒汤结肠透析治疗慢性肾衰临床观察
朱俭1,(), 王英丽1   
  1. 1. 163311 黑龙江省大庆市中医医院肾病风湿科
  • 收稿日期:2015-06-30 出版日期:2015-12-15
  • 通信作者: 朱俭

Clinical observation on the treatment of chronic renal failure by colon dialysis with clear-kidney detoxification soup

Jian Zhu1,(), Yingli Wang1   

  1. 1. Kidney Disease Rheumatology,Daqing City Hospital of Traditional Chinese Medicine,Daqing 163311,China
  • Received:2015-06-30 Published:2015-12-15
  • Corresponding author: Jian Zhu
引用本文:

朱俭, 王英丽. 清肾排毒汤结肠透析治疗慢性肾衰临床观察[J/OL]. 中华针灸电子杂志, 2015, 04(06): 255-258.

Jian Zhu, Yingli Wang. Clinical observation on the treatment of chronic renal failure by colon dialysis with clear-kidney detoxification soup[J/OL]. Chinese Journal of Acupuncture and Moxibustion(Electronic Edition), 2015, 04(06): 255-258.

目的

临床观察中药结肠透析治疗慢性肾衰竭的疗效。

方法

选取2013年1月至2015年3月大庆市中医医院肾病风湿科的慢性肾功能衰竭住院患者60例。治疗组和对照组各30例。治疗组应用清肾排毒汤结肠透析;对照组以常规结肠透析方法。观察治疗前后患者症状改善,肾功能变化情况及2种方法的疗效比较。采用SPSS13.0统计学软件进行统计分析,计量资料用均数±标准差(±s)表示,采用t检验,计数资料用χ2检验,以P﹤0.05为差异有统计学意义。

结果

(1)治疗组尿素氮、血肌酐及血尿酸分别为(19±8)mmol/L、(412±26)μ mol/L、(474±42)μmol/L;对照组分别为(14±6)mmol/L、(325±31)μmol/L、(384±57)μmol/L,与对照组比较显著降低,差异有统计学意义(t=4.26、2.85、5.21,均P﹤0.05)。表明清肾排毒汤结肠透析法可显著改善慢性肾衰竭患者肾功能。(2)治疗后两组中医症状积分均下降,治疗组症状积分为(9.4±1.9)分,较对照组(12.2±2.5)分降低,两组间比较差异有统计学意义(t=1.88,P﹤0.05)。(3)临床疗效比较,对照组显效2例,有效10例,稳定12例,无效6例,总有效率80%(24/30);治疗组显效4例,有效14例,稳定9例,无效3例,总有效率90%(27/30)。治疗组疗效优于对照组,两组比较差异有统计学意义(χ2=2.54,P﹤0.05)。

结论

单纯清肾排毒汤中药结肠透析对慢性肾衰在改善肾功能,中医症状及临床疗效方面均优于单纯的结肠透析法,可延缓疾病进展,值得临床推广。

Objective

To observe effectiveness of colon dialysis with traditionalChinese medicine(TCM)for treatment in patients with chronic renal failure.

Methods

Sixty patients with chronic renal failure,in the department of rheumatism,Daqing city,from January 2013 to March 2015,were included in this study.Patients were divided into two groups:treatment group and control group,30 cases in each group.The treatment group was treated with the renal detoxification decoction and the control group was treated with routine colon dialysis method.The improvement of symptoms and the changes of renal function were observed before and after treatment.The SPSS 13.0 statistical software was used for statistical analysis,and measurement data were expressed as mean and standard deviation(±s).The count data were analysed by chi square test.P-values less than or equal to 0.05 were considered statistically significance.

Results

After treatment,levels of urea nitrogen,serum creatinine and serum uric acid were significantly improved[(19±8)mmol/L,(412±26)μmol/L and(474±42)μmol/L]in treatment group compared with those of control group[(14±6)mmol/L,(325±31)μ mol/L and(384±57)μ mol/L],there was a significant difference between two groups(t=4.26,2.85 and 5.21,P﹤0.05).After treatment,the symptom scores were significantly decreased in two groups.The symptom scores were significantly lower in treatment group(9.4±1.9)than those in control group(12.2±2.5,t=1.88,P﹤0.05).In control group,2 cases were markedly effective,10 cases were effective,12 cases were stable,and 6 cases were ineffective.The total effective rate was 80%(24/30).In treatment group 4 cases were markedly effective,14 cases were effective,9 cases were stable and 3 cases were invalid,the total effective rate was 90%(27/30).The curative effect was significantly better in treatment group than that of control group(χ2=2.54,P﹤0.05).

Conclusion

Traditional Chinese medicine colon dialysis of kidney detoxification soup has obvious curative effect on chronic renal failure at early and mid-term,which can delay the progress of diseae and worthy of clinical promotion.

表1 两组治疗后肾功能指标改善情况(±s)
表2 治疗前后2组中医症状积分比较(分,±s)
[1]
葛均波,徐永健.内科学[M].8版.北京:人民卫生出版社,2013.
[2]
陈钦,李娜,朱芸芸,等.中药结肠透析治疗慢性肾脏病(CKD)Ⅲ-Ⅴ期的最佳治疗频率探讨[J].中华中医药学刊,2015,33(2):378-380.
[3]
张秋林,蔡仕辉.肾衰宁胶囊联合贝那普利治疗慢性肾功能衰竭临床研究[J].湖北中医药大学学报,2014,16(1):82-84.
[4]
熊飞,张燕敏,陈伟栋,等.结肠透析治疗慢性肾衰竭的有效性和安全性[J].中国中西医结合肾病杂志,2013,14(12):1108-1110.
[5]
余春,童安荣,魏冬梅.中药结肠透析治疗慢性肾功能衰竭探析[J].陕西中医,2011,32(2):189-190.
[1] 周涵, 武胡雯, 张培深, 邓晗彬, 范闻轩, 李嘉诚, 程少文. 蛋白质组学在慢性难愈合创面研究中的应用进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 536-540.
[2] 罗宸婧, 盛芳芳, 张静, 王关嵩, 秦蘅, 顾鹏. 以全球视角对中国慢性阻塞性肺疾病负担及未来趋势分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(06): 855-860.
[3] 张诚实, 陈荣荣, 秦二云, 张青, 刘明, 冯契靓, 赵云峰. 动态测定血浆长链非编码RNA SOX2-OT在COPD 相关性肺动脉高压患者中的临床意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(06): 895-900.
[4] 成鹏, 席常青, 赵涛, 李军孝, 陈其亮. 慢性结核性脓胸术后肺复张影响因素分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(06): 920-924.
[5] 李姣, 张莉, 侯云秋, 孙腾, 梁艳, 霍博. 预警机制在AECOPD 并发呼吸衰竭全方位无盲点管理中的应用分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(06): 948-952.
[6] 沈柳柳, 周不畏, 王敏, 卢春霞, 邢燕飞. 个体化肺康复及情绪调节对AECOPD并VTE 高危患者生活质量和预后影响分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(06): 971-974.
[7] 马强. 衰弱和肌少症对肾功能评估的影响及干预策略[J/OL]. 中华肾病研究电子杂志, 2025, 14(01): 60-60.
[8] 王欢, 王洪峰, 金重珍, 彭小芬, 金艳华, 张德伟, 张艳宁. 中性粒细胞与淋巴细胞比值对腹膜透析糖尿病患者心血管疾病死亡风险的预测作用[J/OL]. 中华肾病研究电子杂志, 2025, 14(01): 7-12.
[9] 刘键, 谭志广, 郝文联, 张晓娜, 王建雄, 徐宏娟, 彭丽敏, 于海霞, 李晨曦. 血液透析患者手指血钾微流体技术检测法的建立[J/OL]. 中华肾病研究电子杂志, 2025, 14(01): 13-17.
[10] 蔡青利, 汪晓月, 陈客宏, 喻芳. 抑制组蛋白乳酸化修饰减轻高糖腹膜透析液诱导的腹膜炎症[J/OL]. 中华肾病研究电子杂志, 2025, 14(01): 34-43.
[11] 余永武, 熊敏, 张凌. 慢性肾脏病矿物质和骨异常药物治疗研究新进展[J/OL]. 中华肾病研究电子杂志, 2025, 14(01): 44-47.
[12] 马红, 陈祎琦, 张艺馨, 任杨, 蔡玉辉, 王磊, 朱兴华, 张逸. 可注射型富血小板纤维蛋白联合人工真皮在慢性难愈合创面治疗中的应用研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(10): 917-925.
[13] 贾玲玲, 滕飞, 常键, 黄福, 刘剑萍. 心肺康复在各种疾病中应用的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 859-862.
[14] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[15] 闫维, 张二明, 张克, 安欣华, 向平超. 北京市石景山区40岁及以上居民早期慢性阻塞性肺疾病异质性及影响因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 533-540.
阅读次数
全文


摘要